Search

everythinglearnresearchcommunity

for

Search:↓

Certain inhibitors can potentially treat prostate cancer and other hormone-dependent conditions by controlling sex hormone levels in cells.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

Hormone therapy for trans individuals is effective and generally safe in the short term.

Testosterone therapy seems safe and effective for transgender men with proper care, but more long-term research is needed.

Hormones are crucial for regulating body functions and imbalances can lead to health issues.

Prolactin affects hair growth and skin conditions, and could be a target for new skin disease treatments.

SHBG may be a useful early indicator and treatment target for PCOS.

Hormone therapy for transgender females increases the risk of blood clots and requires careful dosing, monitoring, and lifelong management.

Menopause affects hair and skin; more research needed for treatment.

Girls with PCOS and menstrual disorders have notably higher androgen hormone levels.

Men and women experience skin aging differently due to changes in sex hormone levels with age.

Women with PCOS have higher levels of AMH in their blood and follicles, and this can help predict their risk of overreaction to fertility treatments.

Women with PCOS have a higher risk of heart disease due to factors like insulin resistance and obesity.

The document suggests that blocking sweat glands with antiperspirants might allow skin-generated hormones to be absorbed, possibly increasing breast and prostate cancer risk.

Androgen therapy can help with symptoms like low libido in women, but more research is needed to understand its long-term safety and effects on health.

CDK4/6 inhibitors have improved treatment outcomes for certain advanced breast cancer patients.

PCOS involves hormonal imbalance, cysts, and ovulation issues, affecting health and increasing disease risks.

Polycystic ovary syndrome and iron overload share similar symptoms and can be potentially treated with blood removal, diet changes, and probiotics.

The document concludes that early recognition and treatment of PCOS in adolescents is crucial for managing symptoms and long-term health risks.

Hormonal treatments are effective as a second-line option for moderate-to-severe acne in females, but should be used with caution due to health risks.

Hormonal therapy is a treatment option for acne, the only medical treatment for hirsutism, and the most promising for androgenetic alopecia.

Transgender youth on hormone therapy need personalized acne treatments and supportive care.

The document says menstruation is important for women's health, discusses menstrual disorders, and suggests personalized treatment options.

The document concludes that hormonal biomarkers are key for diagnosing hyperandrogenemia in women and hypogonadism in men.

The document concludes that individualized treatment and lifestyle changes are important for managing menopause symptoms and health risks.

Hormonal imbalances are a key cause of missed menstrual periods in women.

Gene mutations can cause problems in male genital development.

The guideline recommends mental health involvement in diagnosing gender identity disorder and outlines hormone and surgical treatment protocols, emphasizing safety, informed consent, and long-term monitoring.

AMH helps estimate ovarian reserve but doesn't predict pregnancy chances; age is more important.

Testosterone replacement may help post-menopausal women with androgen insufficiency, but more research is needed on its benefits and risks.